These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 30935459)
21. Management of acute kidney injury in symptomatic multiple myeloma. Bridoux F; Leung N; Belmouaz M; Royal V; Ronco P; Nasr SH; Fermand JP; Kidney Int; 2021 Mar; 99(3):570-580. PubMed ID: 33440212 [TBL] [Abstract][Full Text] [Related]
22. Haemodialysis using high cut-off dialysers for treating acute renal failure in multiple myeloma. Martín-Reyes G; Toledo-Rojas R; Torres-de Rueda Á; Sola-Moyano E; Blanca-Martos L; Fuentes-Sánchez L; Martínez-Esteban MD; Díez-de los Ríos MJ; Bailén-García A; González-Molina M; García-González I Nefrologia; 2012; 32(1):35-43. PubMed ID: 22294003 [TBL] [Abstract][Full Text] [Related]
23. [A case of IgG-kappa type multiple myeloma complicated by Fanconi syndrome]. Sakaue S; Nakata K; Nagata H; Yamaguchi J Rinsho Ketsueki; 1994 Aug; 35(8):786-91. PubMed ID: 7933567 [TBL] [Abstract][Full Text] [Related]
24. Diagnostic reference range of κ/λ free light chain ratio to screen for Bence Jones proteinuria is not significantly influenced by GFR. Schmidt-Hieltjes Y; Elshof C; Roovers L; Ruinemans-Koerts J Eur J Haematol; 2016 May; 96(5):527-31. PubMed ID: 26172558 [TBL] [Abstract][Full Text] [Related]
25. Differential progression of renal scarring and determinants of late renal recovery in sustained dialysis dependent acute kidney injury secondary to myeloma kidney. Basnayake K; Cheung CK; Sheaff M; Fuggle W; Kamel D; Nakoinz S; Hutchison CA; Cook M; Stoves J; Bradwell AR; Cockwell P J Clin Pathol; 2010 Oct; 63(10):884-7. PubMed ID: 20876319 [TBL] [Abstract][Full Text] [Related]
26. Myeloma kidney: the importance of assessing the response by monitoring free light chains in serum. Martín-Gómez MA; García-Marcos SA; Caba-Molina M; Palacios-Gómez ME; Gómez-Morales M; Claver-Ferré C Nefrologia; 2013 Nov; 33(6):862-4. PubMed ID: 24241381 [No Abstract] [Full Text] [Related]
28. Prognostic value of kidney biopsy in myeloma cast nephropathy: a retrospective study of 70 patients. Ecotière L; Thierry A; Debiais-Delpech C; Chevret S; Javaugue V; Desport E; Belmouaz S; Quellard N; Kaaki S; Goujon JM; Fermand JP; Touchard G; Bridoux F Nephrol Dial Transplant; 2016 Jan; 31(1):64-72. PubMed ID: 26289418 [TBL] [Abstract][Full Text] [Related]
29. Myeloma kidney cast nephropathy in a rat model of multiple myeloma. Smolens P; Venkatachalam M; Stein JH Kidney Int; 1983 Aug; 24(2):192-204. PubMed ID: 6415338 [TBL] [Abstract][Full Text] [Related]
30. Novel renal replacement strategies for the elimination of serum free light chains in patients with kappa light chain nephropathy. Kleeberg L; Morgera S; Jakob C; Hocher B; Schneider M; Peters H; Rötzer S; Müller C; Kaiser M; Fleissner C; Heider U; Neumayer HH; Sezer O Eur J Med Res; 2009; 14(2):47-54. PubMed ID: 19258212 [TBL] [Abstract][Full Text] [Related]
31. Coincidental crystalline light chain cast nephropathy, light chain proximal tubulopathy, and urine crystallopathy: A case report and review of the literature . Lerner G; Moradi S; Cohen-Bucay A; Chen H; Sanchorawala V; Gordon CE; Henderson JM Clin Nephrol; 2020 Apr; 93(4):203-208. PubMed ID: 31907143 [TBL] [Abstract][Full Text] [Related]
32. Adult Fanconi syndrome secondary to kappa-light chain myeloma: improvement of tubular functions after treatment for myeloma. Uchida S; Matsuda O; Yokota T; Takemura T; Ando R; Kanemitsu H; Hamaguchi H; Miyake S; Marumo F Nephron; 1990; 55(3):332-5. PubMed ID: 2115147 [TBL] [Abstract][Full Text] [Related]
33. Extracorporeal light chain elimination: high cut-off (HCO) hemodialysis parallel to chemotherapy allows for a high proportion of renal recovery in multiple myeloma patients with dialysis-dependent acute kidney injury. Heyne N; Denecke B; Guthoff M; Oehrlein K; Kanz L; Häring HU; Weisel KC Ann Hematol; 2012 May; 91(5):729-735. PubMed ID: 22170517 [TBL] [Abstract][Full Text] [Related]
35. [An unusual case of multiple myeloma diagnosed by a noticeable decrease in the serum M-component level]. Kanoh T Rinsho Ketsueki; 1996 Dec; 37(12):1416-21. PubMed ID: 8997132 [TBL] [Abstract][Full Text] [Related]